Encompass Health
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$5.12B N/A	$4.34B -15.09%	$4.80B 10.40%	Avg: $5.77B Low: $5.71B High: $5.83B avg. 20.35%	Avg: $6.29B Low: $6.24B High: $6.35B avg. 8.89%	Avg: $5.11B Low: $5.07B High: $5.16B avg. -18.66%
Net Income % change YoY	$412.2M N/A	$271M -34.25%	$352M 29.88%	Avg: $463.79M Low: $411.27M High: $504.47M avg. 31.76%	Avg: $488.15M Low: $452.81M High: $499.40M avg. 5.25%	Avg: $563.22M Low: $557.64M High: $569.94M avg. 15.38%
EBITDA % change YoY	$1.07B N/A	$871.5M -19.26%	$1.02B 17.56%	Avg: $1.18B Low: $1.16B High: $1.19B avg. 15.21%	Avg: $1.28B Low: $1.27B High: $1.29B avg. 8.89%	Avg: $1.04B Low: $1.03B High: $1.05B avg. -18.66%
EPS % change YoY	$4.15 N/A	$2.72 -34.45%	$3.54 30.14%	Avg: $4.51 Low: $4.06 High: $4.98 avg. 27.30%	Avg: $4.7 Low: $4.47 High: $4.93 avg. 4.28%	Avg: $5.56 Low: $5.5 High: $5.63 avg. 18.29%
Operating Expenses % change YoY	$4.10B N/A	$3.51B -14.35%	$693.9M -80.26%	Avg: $2.90B Low: $2.87B High: $2.93B avg. 319.19%	Avg: $3.16B Low: $3.14B High: $3.19B avg. 8.89%	Avg: $2.57B Low: $2.55B High: $2.60B avg. -18.66%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 17.46% in 2025-2027.

We have gathered data from 7 analysts. Their low estimate is 411.27M, average is 463.79M and high is 504.47M.

Wall Street analysts forecast annual average revenue growth of 3.52% in 2025-2027.

We have gathered data from 9 analysts. Their low revenue estimate is $5.71B, average is $5.77B and high is $5.83B.

Wall Street analysts forecast annual average earnings growth of 16.63% in 2025-2027.

We have gathered data from 7 analysts. Their low earnings per share estimate is $4.06, average is $4.51 and high is $4.98.

In the last twelve months analysts have been covering Encompass Health stock. The most successful analyst is Frank Morgan.